Literature DB >> 8986744

Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys.

M J Crowe1, J C Bresnahan, S L Shuman, J N Masters, M S Beattie.   

Abstract

Apoptosis is a morphologically defined form of programmed cell death seen in a variety of circumstances, including immune cell selection, carcinogenesis and development. Apoptosis has very recently been seen after ischemic or traumatic injury to the central nervous system (CNS), suggesting that active cell death as well as passive necrosis may mediate damage after CNS injury. After spinal cord injury (SCI) in the rat, typical post-traumatic necrosis occurred, but in addition, apoptotic cells were found from 6 hours to 3 weeks after injury, especially in the spinal white matter. Apoptotic cells were positive for oligodendrocyte markers. After SCI in monkeys, apoptotic cells were found within remote degenerating fiber tracts. Both secondary degeneration at the site of SCI and the chronic demyelination of tracts away from the injury appear to be due in part to apoptosis. As cytokines have been shown to mediate oligodendrocyte death in vitro, it seems likely that chronic demyelination after CNS injury shares features with chronic degenerative disorders like multiple sclerosis.

Entities:  

Mesh:

Year:  1997        PMID: 8986744     DOI: 10.1038/nm0197-73

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  303 in total

1.  Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord.

Authors:  D M McTigue; P Wei; B T Stokes
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

2.  ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury.

Authors:  Michael S Beattie; Anthony W Harrington; Ramee Lee; Ju Young Kim; Sheri L Boyce; Frank M Longo; Jacqueline C Bresnahan; Barbara L Hempstead; Sung Ok Yoon
Journal:  Neuron       Date:  2002-10-24       Impact factor: 17.173

3.  Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.

Authors:  Jee Y Lee; So R Kang; Tae Y Yune
Journal:  J Neurotrauma       Date:  2015-03-06       Impact factor: 5.269

Review 4.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

5.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

6.  PTEN inhibitor bisperoxovanadium protects oligodendrocytes and myelin and prevents neuronal atrophy in adult rats following cervical hemicontusive spinal cord injury.

Authors:  Chandler L Walker; Xiao-Ming Xu
Journal:  Neurosci Lett       Date:  2014-02-26       Impact factor: 3.046

7.  Evaluation of hyperbaric oxygen therapy for spinal cord injury in rats with different treatment course using diffusion tensor imaging.

Authors:  Fang Liu; Libin Yang; Jianyi Liu; Yijing Zhao; Zebin Xiao; Yingyan Zheng; Zhen Xing; Yuyang Zhang; Dairong Cao
Journal:  Spinal Cord       Date:  2019-01-14       Impact factor: 2.772

8.  Significant correlation between cerebrospinal fluid nitric oxide concentrations and neurologic prognosis in incomplete cervical cord injury.

Authors:  Noboru Hosaka; Shinji Kimura; Akiyoshi Yamazaki; Xianjun Wang; Hiroshi Denda; Takui Ito; Toru Hirano; Naoto Endo
Journal:  Eur Spine J       Date:  2007-08-22       Impact factor: 3.134

Review 9.  Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair.

Authors:  Inés Maldonado-Lasunción; Joost Verhaagen; Martin Oudega
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

10.  Genetic ablation of receptor for advanced glycation end products promotes functional recovery in mouse model of spinal cord injury.

Authors:  Ji-Dong Guo; Li Li; Ya-Min Shi; Hua-Dong Wang; Yan-Li Yuan; Xiu-Xiu Shi; Shu-Xun Hou
Journal:  Mol Cell Biochem       Date:  2014-02-14       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.